A 42-year-old cisgender man with HIV was diagnosed with disseminated Mycobacterium avium complex (MAC) infection 18 months ago. He has been receiving treatment for disseminated MAC and antiretroviral therapy. He has achieved virologic suppression for 16 months, and he currently has no symptoms. The most recent laboratory studies showed a CD4 count of 89 cells/mm3.
When can this man discontinue chronic maintenance therapy (secondary prophylaxis) for MAC?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 28th, 2023
September 28th, 2023
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5